Chapter 17 Current treatment of myasthenia gravis
- 1 January 1990
- book chapter
- Published by Elsevier
- Vol. 84, 151-161
- https://doi.org/10.1016/s0079-6123(08)60899-7
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Effects of Repeated Doses of Intravenous Immunoglobulin in Myasthenia GravisThe Lancet Healthy Longevity, 1988
- Immediate effects of intravenous IgG administration on peripheral blood B and T cells and polymorphonuclear cells in patients with myasthenia gravisJournal of Clinical Immunology, 1988
- Clinical Pharmacokinetics of Cholinesterase InhibitorsClinical Pharmacokinetics, 1986
- High-Dose Intravenous Methylprednisolone in Myasthenia GravisArchives of Neurology, 1985
- Clinical pharmacology of pyridostigmine and neostigmine in patients with myasthenia gravis.Journal of Neurology, Neurosurgery & Psychiatry, 1983
- The relationship of plasma levels of pyridostigmine to clinical effect in patients with myasthenia gravisJournal of Neurology, Neurosurgery & Psychiatry, 1981
- Pharmacokinetics and oral bioavailability of pyridostigmine in manEuropean Journal of Clinical Pharmacology, 1980
- The Value of Thymectomy in Myasthenia GravisAnnals of Surgery, 1976
- CORTICOTROPIN AND CORTICOSTEROIDS IN GENERALIZED MYASTHENIA GRAVIS: COMPARATIVE STUDIES AND ROLE IN MANAGEMENTAnnals of the New York Academy of Sciences, 1976
- The Effect of Thoracic Duct Lymph Drainage in Myasthenia gravisEuropean Neurology, 1973